A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Oxyphenbutazone | CAS 129-20-4 - Request Quote

Picture of Oxyphenbutazone

Oxyphenbutazone

SZ CAT No:SZ-O072001
CAS No
129-20-4
Mol.F.
C19H20N2O3
Mol.Wt.
324.4
Inv. Status
Synthesis on demand
Rel. CAS No7081-38-1 (hydrate)

Chemical Name :

Shipping Temperature :

HSN Code :

Country of Origin :

Smiles :

Usage Note:

Oxyphenbutazone is chemically 4-Butyl-1-(4-hydroxyphenyl)-2-phenylpyrazolidine-3,5-dione. Oxyphenbutazone is supplied with detailed characterization data compliant with regulatory guideline. Oxyphenbutazone can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Oxyphenbutazone.

The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.

Applications & Regulatory Use Cases

Buy 129-20-4

Purchase 129-20-4

Order 129-20-4

Enquire 129-20-4

price of 129-20-4

129-20-4 Supplier

129-20-4 Manufacturer

129-20-4 Exporter

buy high quality Oxyphenbutazone

Purchase Oxyphenbutazone

Oxyphenbutazone suppliers

Oxyphenbutazone manufacturers

Oxyphenbutazone price

Order Oxyphenbutazone

Enquire Oxyphenbutazone

Oxyphenbutazone cost

Oxyphenbutazone Supplier

Oxyphenbutazone Distributor

Oxyphenbutazone for Method Validation

Oxyphenbutazone Reference Standard

Oxyphenbutazone for ANDA Filing

Oxyphenbutazone for Forced Degradation Studies

Oxyphenbutazone Identification Standards

Oxyphenbutazone for DMF Filing

ℹ️

Disclaimer

SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.

SynZeal will update these details as per new developments or findings in product specifications without further notice.

,